Αποτελέσματα αναζήτησης - Stan Kaye
- Εμφανίζονται 1 - 2 Αποτελέσματα από 2
-
1
Randomized Phase II Placebo-Controlled Trial of Maintenance Therapy Using the Oral Triple Angiokinase Inhibitor BIBF 1120 After Chemotherapy for Relapsed Ovarian Cancer από Jonathan A. Ledermann, Allan Hackshaw, Stan Kaye, Gordon C. Jayson, Hani Gabra, Iain A. McNeish, Helena Earl, Timothy Perren, Martin Gore, Mojca Persic, Malcolm Adams, Lindsay E. James, Graham Temple, Michael Merger, Gordon Rustin
Έκδοση 2011Artigo -
2
Long-Term Responders on Olaparib Maintenance in High-Grade Serous Ovarian Cancer: Clinical and Molecular Characterization από Stéphanie Lheureux, Zhongwu Lai, Brian Dougherty, Sarah Runswick, Darren Hodgson, Kirsten M. Timms, Jerry S. Lanchbury, Stan Kaye, Charlie Gourley, David D.L. Bowtell, Elise C. Kohn, Clare L. Scott, Ursula A. Matulonis, Tony Panzarella, Katherine Karakasis, Julia V. Burnier, C. Blake Gilks, Mark J. O’Connor, Jane Robertson, Jonathan A. Ledermann, J. Carl Barrett, Tony W. Ho, Amit M. Oza
Έκδοση 2017Artigo
Εργαλεία αναζήτησης:
Σχετικά θέματα
Internal medicine
Medicine
Oncology
Adverse effect
Alternative medicine
BRCA mutation
Biology
Cancer
Cancer research
Chemotherapy
Confidence interval
Gastroenterology
Gene
Genetics
Hazard ratio
Olaparib
Ovarian cancer
PARP inhibitor
Pathology
Placebo
Poly ADP ribose polymerase
Polymerase
Serous ovarian cancer
Surgery